Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Non Operating Income: 2012-2024

Historic Non Operating Income for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to -$21.7 million.

  • Ocular Therapeutix's Non Operating Income fell 107.57% to -$720,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 103.50%. This contributed to the annual value of -$21.7 million for FY2024, which is 1419.87% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Non Operating Income of -$21.7 million as of FY2024, which was down 1,419.87% from $1.6 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Non Operating Income ranged from a high of $71.5 million in FY2021 and a low of -$92.8 million during FY2020.
  • For the 3-year period, Ocular Therapeutix's Non Operating Income averaged around -$4.2 million, with its median value being $1.6 million (2023).
  • As far as peak fluctuations go, Ocular Therapeutix's Non Operating Income plummeted by 16,178.77% in 2020, and later surged by 177.04% in 2021.
  • Over the past 5 years, Ocular Therapeutix's Non Operating Income (Yearly) stood at -$92.8 million in 2020, then spiked by 177.04% to $71.5 million in 2021, then crashed by 89.35% to $7.6 million in 2022, then crashed by 78.39% to $1.6 million in 2023, then crashed by 1,419.87% to -$21.7 million in 2024.